If you look at the chart for the iShares U.S. Medical Devices ETF (IHI) lately, you might think the sector is flatlining. After a decade of being the steady pulse of a healthcare portfolio, medical device stocks have entered 2026 in what can only be described as a state of cardiac arrest.
Between the rising GLP-1 fever and a new wave of tariff-induced margin pressure, the sector is currently waiting for a jolt of electricity to bring it back to life.
